Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
United Therapeutics
UTHR
|
+$473M |
| 2 |
Intel
INTC
|
+$412M |
| 3 |
Amazon
AMZN
|
+$396M |
| 4 |
Microsoft
MSFT
|
+$385M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$373M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$309M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 3 |
TSMC
TSM
|
+$246M |
| 4 |
NVIDIA
NVDA
|
+$212M |
| 5 |
Bank of America
BAC
|
+$191M |
Sector Composition
| 1 | Technology | 29.65% |
| 2 | Consumer Discretionary | 10.15% |
| 3 | Healthcare | 9.29% |
| 4 | Financials | 8.19% |
| 5 | Communication Services | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Amneal Pharmaceuticals
AMRX
$3.07B
| $460K | ﹤0.01% |
72,383
+6,254
| +9% | +$39.7K |
|
|
LADR
2627
Ladder Capital
LADR
$1.46B
| $459K | ﹤0.01% |
40,690
+5,560
| +16% | +$62.8K |
|
2628
AvidXchange
AVDX
$2.07B
| $459K | ﹤0.01% |
38,052
+11,334
| +42% | +$137K |
|
2629
Vaalco Energy
EGY
$422M
| $455K | ﹤0.01% |
72,621
-8,654
| -11% | -$54.3K |
|
2630
Steelcase
SCS
$1.94B
| $455K | ﹤0.01% |
35,129
+4,875
| +16% | +$63.2K |
|
2631
Carter's
CRI
$1.14B
| $455K | ﹤0.01% |
7,344
-15,541
| -68% | -$963K |
|
2632
Community Health Systems
CYH
$411M
| $455K | ﹤0.01% |
135,378
+109,343
| +420% | +$367K |
|
2633
Savara
SVRA
$624M
| $455K | ﹤0.01% |
112,818
+95,498
| +551% | +$385K |
|
2634
Spyre Therapeutics
SYRE
$896M
| $454K | ﹤0.01% |
19,320
-12,437
| -39% | -$292K |
|
2635
Iridium Communications
IRDM
$1.93B
| $453K | ﹤0.01% |
17,034
-27,393
| -62% | -$729K |
|
2636
Ingles Markets
IMKTA
$1.31B
| $453K | ﹤0.01% |
6,596
+1,756
| +36% | +$120K |
|
2637
Schneider National
SNDR
$4.19B
| $452K | ﹤0.01% |
18,689
-20,614
| -52% | -$498K |
|
2638
DXP Enterprises
DXPE
$1.84B
| $451K | ﹤0.01% |
9,847
+565
| +6% | +$25.9K |
|
2639
Clearway Energy Class A
CWEN.A
$3.21B
| $451K | ﹤0.01% |
19,917
+2,813
| +16% | +$63.7K |
|
2640
Gossamer Bio
GOSS
$723M
| $450K | ﹤0.01% |
500,003
-1,787,777
| -78% | -$1.61M |
|
2641
Fulgent Genetics
FLGT
$673M
| $448K | ﹤0.01% |
22,856
+2,173
| +11% | +$42.6K |
|
2642
Soleno Therapeutics
SLNO
$2.72B
| $447K | ﹤0.01% |
10,948
-86,806
| -89% | -$3.54M |
|
2643
National Grid
NGG
$71.1B
| $446K | ﹤0.01% |
8,216
-1,616
| -16% | -$87.7K |
|
|
INVX
2644
Innovex International, Inc.
INVX
$1.14B
| $445K | ﹤0.01% |
23,949
+1,802
| +8% | +$33.5K |
|
2645
Zillow
ZG
$20.3B
| $445K | ﹤0.01% |
9,885
-18,214
| -65% | -$820K |
|
2646
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$3.68B
| $444K | ﹤0.01% |
5,871
+4,106
| +233% | +$311K |
|
2647
Bandwidth Inc
BAND
$511M
| $443K | ﹤0.01% |
26,218
+3,999
| +18% | +$67.5K |
|
2648
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$4.31B
| $441K | ﹤0.01% |
13,116
-1,195
| -8% | -$40.2K |
|
2649
Ocular Therapeutix
OCUL
$2.18B
| $440K | ﹤0.01% |
64,310
-53,995
| -46% | -$369K |
|
2650
Virgin Galactic
SPCE
$189M
| $439K | ﹤0.01% |
52,062
-25,684
| -33% | -$217K |
|